Transcutaneous retrobulbar amphotericin B for rhino-orbital-cerebral mucormycosis: a multi-center retrospective comparative study

References

• Colon-Acevedo B, Kumar J, Richard MJ, Woodward JA. The role of adjunctive therapies in the management of invasive sino-orbital infection. Ophthalmic Plast Reconstr Surg. 2015;31(5):401–405. doi:10.1097/IOP.0000000000000488.
   PubMed Web of Science ®Google Scholar
• Prabhu RM, Patel R. Mucormycosis and entomophthoramycosis: a review of the clinical manifestations, diagnosis and treatment. Clin Microbiol Infect. 2004;10(Suppl 1):31–47. doi:10.1111/j.1470-9465.2004.00843.x.
   PubMed Web of Science ®Google Scholar
• Riad A, Shabaan AA, Issa J, Ibrahim S, Amer H, Mansy Y, et al. COVID-19-associated mucormycosis (CAM): case-series and global analysis of mortality risk Factors. J Fungi (Basel). 2021;7(10):837. doi:10.3390/jof7100837.
   PubMedGoogle Scholar
• Chao CM, Lai CC, Yu WL. COVID-19 associated mucormycosis - an emerging threat. J Microbiol Immunol Infect. 2022;55(2):183–190.
   PubMedGoogle Scholar
• Dallalzadeh LO, Ozzello DJ, Liu CY, Kikkawa DO, Korn BS. Secondary infection with rhino-orbital cerebral mucormycosis associated with COVID-19. Orbit. 2021:1–4. doi:10.1080/01676830.2021.1903044.
   Google Scholar
• Sen M, Honavar SG, Bansal R, Sengupta S, Rao R, Kim U, et al. Epidemiology, clinical profile, management, and outcome of COVID-19-associated rhino-orbital-cerebral mucormycosis in 2826 patients in India - Collaborative OPAI-IJO Study on Mucormycosis in COVID-19 (COSMIC), Report 1. Indian J Ophthalmol. 2021;69(7):1670–1692. doi:10.4103/ijo.IJO_1565_21.
   PubMed Web of Science ®Google Scholar
• Dave TV, Gopinathan Nair A, Hegde R, Vithalani N, Desai S, Adulkar N, et al. Clinical presentations, management and outcomes of rhino-orbital-cerebral mucormycosis (ROCM) following COVID-19: a multi-centric study. Ophthalmic Plast Reconstr Surg. 2021;37(5):488–495. doi:10.1097/IOP.0000000000002030.
   PubMed Web of Science ®Google Scholar
• Fakhar M, Sharifpour A, Zakariaei Z, Banimostafavi ES, Soleymani M, Davoodi L. Rhino-orbito-cerebral mucormycosis in a post-COVID-19 diabetic patient: rare case from Iran. Clin Case Rep. 2022;10(2):e05506. doi:10.1002/ccr3.5506.
   PubMed Web of Science ®Google Scholar
• Patel R, Jethva J, Bhagat PR, Prajapati V, Thakkar H, Prajapati K. Rhino-orbital-cerebral mucormycosis: an epidemiological study from a tertiary care referral center in Western India. Indian J Ophthalmol. 2022;70(4):1371–1375. doi:10.4103/ijo.IJO_2943_21.
   PubMed Web of Science ®Google Scholar
• Mohammadi F, Badri M, Safari S, Hemmat N. A case report of rhino-facial mucormycosis in a non-diabetic patient with COVID-19: a systematic review of literature and current update. BMC Infect Dis. 2021;21(1):906. doi:10.1186/s12879-021-06625-3.
   PubMed Web of Science ®Google Scholar
• Nair AG, Adulkar AG, D’Cunha L, Rao PR, Bradoo RA, Bapaye M, et al. Rhino-orbital mucormycosis following COVID-19 in previously non-diabetic patients. Orbit. 2021;40(6):499–504. doi:10.1080/01676830.2021.1960382.
   PubMed Web of Science ®Google Scholar
• Ibrahim AS, Spellberg B, Avanessian V, Fu Y, Edwards JE. Rhizopus oryzae adheres to, is phagocytosed by, and damages endothelial cells in vitro. Infect Immun. 2005;73(2):778–783. doi:10.1128/IAI.73.2.778-783.2005.
   PubMed Web of Science ®Google Scholar
• Kalin-Hajdu E, Hirabayashi KE, Vagefi MR, Kersten RC. Invasive fungal sinusitis: treatment of the orbit. Curr Opin Ophthalmol. 2017;28(5):522–533. doi:10.1097/ICU.0000000000000394.
   PubMed Web of Science ®Google Scholar
• Trief D, Gray ST, Jakobiec FA, Durand ML, Fay A, Freitag SK, et al. Invasive fungal disease of the sinus and orbit: a comparison between mucormycosis and Aspergillus. Br J Ophthalmol. 2016;100(2):184–188. doi:10.1136/bjophthalmol-2015-306945.
   PubMed Web of Science ®Google Scholar
• Turner JH, Soudry E, Nayak JV, Hwang PH. Survival outcomes in acute invasive fungal sinusitis: a systematic review and quantitative synthesis of published evidence. Laryngoscope. 2013;123(5):1112–1118. doi:10.1002/lary.23912.
   PubMed Web of Science ®Google Scholar
• Yohai RA, Bullock JD, Aziz AA, Markert RJ. Survival factors in rhino-orbital-cerebral mucormycosis. Surv Ophthalmol. 1994;39(1):3–22. doi:10.1016/S0039-6257(05)80041-4.
   PubMed Web of Science ®Google Scholar
• Riley TT, Muzny CA, Swiatlo E, Legendre DP. Breaking the mold: a review of mucormycosis and current pharmacological treatment options. Ann Pharmacother. 2016;50(9):747–757. doi:10.1177/1060028016655425.
   PubMed Web of Science ®Google Scholar
• Couch L, Theilen F, Mader JT. Rhinocerebral mucormycosis with cerebral extension successfully treated with adjunctive hyperbaric oxygen therapy. Arch Otolaryngol Head Neck Surg. 1988;114:791–794. doi:10.1001/archotol.1988.01860190095032.
   PubMedGoogle Scholar
• Ferguson BJ, Mitchell TG, Moon R, Camporesi EM, Farmer J. Adjunctive hyperbaric oxygen for treatment of rhinocerebral mucormycosis. Rev Infect Dis. 1988;10:551–559. doi:10.1093/clinids/10.3.551.
   PubMedGoogle Scholar
• Barratt DM, Van Meter K, Asmar P, Nolan T, Trahan C, Garcia-Covarrubias L, et al. Hyperbaric oxygen as an adjunct in zygomycosis: randomized controlled trial in a murine model. Antimicrob Agents Chemother. 2001;45:3601–3602. doi:10.1128/AAC.45.12.3601-3602.2001.
   PubMed Web of Science ®Google Scholar
• Kashkouli MB, Abdolalizadeh P, Oghazian M, Hadi Y, Karimi N, Ghazizadeh M. Outcomes and factors affecting them in patients with rhino-orbito-cerebral mucormycosis. Br J Ophthalmol. 2019;103(10):1460–1465. doi:10.1136/bjophthalmol-2018-312688.
   PubMed Web of Science ®Google Scholar
• Hirabayashi KE, Idowu OO, Kalin-Hajdu E, Oldenburg CE, Brodie FL, Kersten RC, et al. Invasive fungal sinusitis: risk factors for visual acuity outcomes and mortality. Ophthalmic Plast Reconstr Surg. 2019;35(6):535–542. doi:10.1097/IOP.0000000000001357.
   PubMed Web of Science ®Google Scholar
• Hargrove RN, Wesley RE, Klippenstein KA, Fleming JC, Haik BG. Indications for orbital exenteration in mucormycosis. Ophthal Plast Reconstr Surg. 2006;22:286–291. doi:10.1097/01.iop.0000225418.50441.ee.
   PubMed Web of Science ®Google Scholar
• Luna JD, Ponssa XS, Rodríguez SD, Luna NC, Jaurez CP. Intraconal amphotericin B for the treatment of rhino-orbital mucormycosis. Ophthalmic Surg Lasers. 1996;27:706–708. doi:10.3928/1542-8877-19960801-10.
   PubMedGoogle Scholar
• Athavale DD, Jones R, O’Donnell BA, Forer M, Biggs N. Non-exenteration management of sino-orbital fungal disease. Ophthalmic Plast Reconstr Surg. 2017;33(6):426–429. doi:10.1097/IOP.0000000000000812.
   PubMed Web of Science ®Google Scholar
• Pelton RW, Peterson EA, Patel BC, Davis K. Successful treatment of rhino-orbital mucormycosis without exenteration: the use of multiple treatment modalities. Ophthal Plast Reconstr Surg. 2001;17:62–66. doi:10.1097/00002341-200101000-00012.
   PubMed Web of Science ®Google Scholar
• Seiff SR, Choo PH, Carter SR. Role of local amphotericin B therapy for sino-orbital fungal infections. Ophthal Plast Reconstr Surg. 1999;15:28–31. doi:10.1097/00002341-199901000-00007.
   PubMed Web of Science ®Google Scholar
• Kahana A, Lucarelli MJ. Use of radiopaque intraorbital catheter in the treatment of sino-orbito-cranial mucormycosis. Arch Ophthalmol. 2007;125:1714–1715. doi:10.1001/archopht.125.12.1714.
   PubMedGoogle Scholar
• Joos ZP, Patel BC. Intraorbital irrigation of amphotericin B in the treatment of rhino-orbital mucormycosis. Ophthal Plast Reconstr Surg. 2017;33:e13–16. doi:10.1097/IOP.0000000000000377.
   PubMed Web of Science ®Google Scholar
• Saedi B, Sadeghi M, Seilani P. Endoscopic management of rhinocerebral mucormycosis with topical and intra- venous amphotericin B. J Laryngol Otol. 2011;125:807–810. doi:10.1017/S0022215111001289.
   PubMed Web of Science ®Google Scholar
• Hirabayashi KE, Kalin-Hajdu E, Brodie FL, Kersten RC, Russell MS, Vagefi MR. Retrobulbar injection of amphotericin B for orbital mucormycosis. Ophthalmic Plast Reconstr Surg. 2017;33(4):e94–97. doi:10.1097/IOP.0000000000000806.
   PubMed Web of Science ®Google Scholar
• Safi M, Ang MJ, Patel P, Silkiss RZ. Rhino-orbital- cerebral mucormycosis (ROCM) and associated cerebritis treated with adjuvant retrobulbar amphotericin B. Am J Ophthalmol Case Rep. 2020;19:100771. doi:10.1016/j.ajoc.2020.100771.
   PubMedGoogle Scholar
• Ashraf DC, Idowu OO, Hirabayashi KE, Kalin-Hajdu E, Grob SR, Winn BJ, et al. Outcomes of a modified treatment ladder algorithm using retrobulbar amphotericin b for invasive fungal rhino-orbital sinusitis. Am J Ophthalmol. 2021. doi:10.1016/j.ajo.2021.05.025.
   PubMed Web of Science ®Google Scholar
• Schulze-Bonsel K, Feltgen N, Burau H, Hansen L, Bach M. Visual acuities “hand motion” and “counting fingers” can be quantified with the Freiburg visual acuity test. Invest Ophthalmol Vis Sci. 2006;47(3):1236–1240. doi:10.1167/iovs.05-0981.
   PubMed Web of Science ®Google Scholar
• Kupcha AC, Simmons BA, Law JJ, Liu Y, Chen Q, Shriver EM, et al. Association of age-adjusted Charlson comorbidity index with orbital fungal disease outcomes. Ophthalmic Plast Reconstr Surg. 2022;38(1):53–58. doi:10.1097/IOP.0000000000001987.
   PubMed Web of Science ®Google Scholar
• Hamill RJ. Amphotericin B formulations: a comparative review of efficacy and toxicity. Drugs. 2013;73:919–934. doi:10.1007/s40265-013-0069-4.
   PubMed Web of Science ®Google Scholar
• Sau K, Mambula SS, Latz E, Henneke P, Golenbock DT, Levitz SM. The antifungal drug amphotericin B promotes inflammatory cytokine release by a Toll-like receptor- and CD14-dependent mechanism. J Biol Chem. 2003;278(39):37561–37568. doi:10.1074/jbc.M306137200.
   PubMed Web of Science ®Google Scholar
• Nair AG, Dave TV. Transcutaneous retrobulbar injection of amphotericin B in rhino-orbital-cerebral mucormycosis: a review. Orbit. October, 2021;31:1–12. doi:10.1080/01676830.2021.1990351.
   Google Scholar
• Gorovoy IR, Vagefi MR, Russell MS, Gorovoy M, Bloomer MM, Glastonbury CM. Loss of contrast enhancement of the inferior rectus muscle on magnetic resonance imaging in acute fulminant invasive fungal sinusitis. Clin Exp Ophthalmol. 2014;42(9):885–887. doi:10.1111/ceo.12337.
   PubMed Web of Science ®Google Scholar
• Gorovoy IR, Kazanjian M, Kersten RC, Kim HJ, Vagefi MR. Fungal rhinosinusitis and imaging modalities. Saudi J Ophthalmol. 2012;26(4):419–426. doi:10.1016/j.sjopt.2012.08.009.
   PubMedGoogle Scholar
• Horger M, Hebart H, Schimmel H, Vogel M, Brodoefel H, Oechsle K, et al. Disseminated mucormycosis in haematological patients: CT and MRI findings with pathological correlation. Br J Radiol. 2006;79(945):e88–95. doi:10.1259/bjr/16038097.
   PubMedGoogle Scholar
• Kim JH, Kang BC, Lee JH. The prognostic value of gadolinium- enhanced magnetic resonance imaging in acute invasive fungal rhinosinusitis. J Infect. 2015;70(1):88–95. doi:10.1016/j.jinf.2014.07.027.
   PubMed Web of Science ®Google Scholar